Walleye Capital LLC Neurocrine Biosciences Inc Transaction History

Walleye Capital LLC

$24 Billion
Q3 2025

A detailed history of Walleye Capital LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Walleye Capital LLC holds 22,606 shares of NBIX stock, worth $3.27 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

22,606

Previous 27,500 17.8%

Holding current value

$3.27 Million

Previous $3.46 Million 8.19%

% of portfolio

0.01%

Previous 0.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$123.98 - $146.67 $606,758 - $717,802	-4,894 Reduced 17.8%	22,606 $3.17 Million
Q2 2025 Aug 13, 2025	SELL	$87.54 - $128.18 $4.48 Million - $6.56 Million	-51,196 Reduced 65.06%	27,500 $3.46 Million
Q1 2025 May 14, 2025	BUY	$107.22 - $153.29 $7.48 Million - $10.7 Million	69,737 Added 778.4%	78,696 $8.7 Million
Q4 2024 Feb 13, 2025	SELL	$111.62 - $139.44 $8.84 Million - $11 Million	-79,187 Reduced 89.84%	8,959 $1.22 Million
Q3 2024 Nov 14, 2024	BUY	$114.58 - $153.15 $9.57 Million - $12.8 Million	83,559 Added 1821.65%	88,146 $10.1 Million

Q2 2024 Aug 14, 2024	BUY	$130.86 - $143.19 $528,281 - $578,058	4,037 Added 734.0%	4,587 $631,000
Q1 2024 May 15, 2024	BUY	$130.4 - $143.74 $71,720 - $79,057	550 New	550 $75,000
Q3 2023 Nov 14, 2023	BUY	$94.02 - $117.1 $2.89 Million - $3.6 Million	30,713 New	30,713 $3.46 Million
Q1 2023 May 15, 2023	BUY	$94.11 - $123.02 $1.43 Million - $1.87 Million	15,161 New	15,161 $1.53 Million
Q2 2022 Aug 08, 2022	SELL	$75.79 - $100.07 $1.94 Million - $2.56 Million	-25,533 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$72.45 - $94.81 $206,410 - $270,113	-2,849 Reduced 10.04%	25,533 $2.39 Million
Q4 2021 Mar 03, 2022	BUY	$79.65 - $106.22 $1.96 Million - $2.61 Million	24,582 Added 646.89%	28,382 $2.42 Million
Q3 2021 Nov 15, 2021	SELL	$86.18 - $99.03 $360,835 - $414,638	-4,187 Reduced 52.42%	3,800 $364,000
Q2 2021 Aug 16, 2021	BUY	$89.43 - $102.27 $714,277 - $816,830	7,987 New	7,987 $777,000
Q2 2020 Aug 14, 2020	SELL	$85.09 - $130.36 $147,546 - $226,044	-1,734 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$75.11 - $113.76 $532,830 - $807,013	-7,094 Reduced 80.36%	1,734 $150,000
Q4 2019 Feb 14, 2020	BUY	$86.8 - $118.57 $537,378 - $734,066	6,191 Added 234.77%	8,828 $949,000
Q3 2019 Nov 14, 2019	BUY	$83.82 - $101.5 $221,033 - $267,655	2,637 New	2,637 $238,000

Others Institutions Holding NBIX

# of Institutions

725

Shares Held

102M

Call Options Held

230K

Put Options Held

477K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $13.9B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.

Account

Walleye Capital LLC Neurocrine Biosciences Inc Transaction History